Prospective Study of Patients with Persistent Chemotherapy Induced Peripheral Neuropathy
Study of Breast Cancer and Colorectal Cancer Patients with Tingling, Pain, or Numbness after Chemotherapy
Sponsor: Internal
Enrolling: Male and Female Patients
IRB Number: AAAQ2054
Contact: Dawn Hershman MD: 212-305-1945 / dlh23@cumc.columbia.edu
Additional Study Information: This study examines the effects of the study drug, topical menthol, on neuropathic symptoms, such as a tingling, pain or numbness caused by nerve damage, following chemotherapy among breast and colorectal cancer patients.
This study is closed
Investigator
Dawn Hershman, MD
Do You Qualify?
Have you been diagnosed with breast or colorectal cancer? Yes No
Do you have persistent neuropathic pain like tingling, pain, or numbness? Yes No
Have you completed chemotherapy treatment at least 2 years ago? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Dawn Hershman MD
dlh23@cumc.columbia.edu
212-305-1945
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE